Alpha-9 Oncology
Operator of a radiopharmaceutical company intended to improve the diagnosis and treatment of metastatic cancer. The company develops imaging and therapeutic molecules for solid and hematologic maligna...
Valuation
$0
Share Price
N/A
Total Raised
$261.1M
Last Round
N/A